COVID-19-associated vasculitis and vasculopathy.

Area of Science:

• Infectious Diseases
• Cardiovascular Medicine
• Immunology

Background:

• The COVID-19 pandemic has highlighted the significant transmissibility and infectivity of the SARS-CoV-2 virus.
• Emerging evidence indicates SARS-CoV-2 can affect multiple organs, including the circulatory system.
• Viral impact on organs can occur through direct tissue tropism or indirect inflammatory responses.

Discussion:

• COVID-19-associated vasculitis and vasculopathy are increasingly recognized as critical manifestations of SARS-CoV-2 infection.
• These vascular conditions arise from direct viral effects or indirect immune responses, including innate immunity activation and release of inflammatory mediators like cell-free DNA and histones.
• The review focuses on the spectrum of vascular involvement in COVID-19.

Key Insights:

• Vasculitis and vasculopathy are defining features of this virus-induced systemic disease.
• SARS-CoV-2 can directly infect vascular endothelial cells or trigger systemic inflammation affecting blood vessels.
• Understanding these vascular complications is crucial for managing COVID-19 patients.

Outlook:

• Further research is needed to elucidate the precise mechanisms linking SARS-CoV-2 to vasculitis and vasculopathy.
• Long-term implications of COVID-19-associated vascular disease require investigation.
• Developing targeted therapies for vascular complications may improve patient outcomes.